Which species are classified as coagulase-negative Staphylococci?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Coagulase-Negative Staphylococci Species

Coagulase-negative staphylococci (CoNS) comprise all staphylococcal species except Staphylococcus aureus, with the most clinically important species being S. epidermidis, S. haemolyticus, S. lugdunensis, S. hominis, S. saprophyticus, S. capitis, S. warneri, and S. simulans. 1, 2

Primary Species Classification

The CoNS group is defined by the absence of coagulase enzyme production, which distinguishes them from S. aureus (the only coagulase-positive staphylococcus) 1, 2. The major species include:

Most Clinically Relevant Species:

  • S. epidermidis - accounts for 63-73% of CoNS infections and is the most common cause of prosthetic valve endocarditis and catheter-related infections 1, 3, 4, 5
  • S. haemolyticus - second most significant nosocomial pathogen among CoNS 3, 4, 5
  • S. lugdunensis - unique among CoNS for causing virulent infections resembling S. aureus, particularly aggressive endocarditis with high rates of perivalvular extension 1, 2, 6

Other Recognized Species:

  • S. hominis 3, 4, 7
  • S. saprophyticus - specifically associated with acute urethritis 8, 5
  • S. capitis 9, 8, 4
  • S. warneri 7, 10
  • S. simulans 8, 7
  • S. auricularis 8

Clinical Context and Importance

CoNS are primarily healthcare-associated pathogens, causing prosthetic valve endocarditis, catheter-related bloodstream infections, and infections in immunocompromised patients 1, 11, 5. While traditionally considered less virulent than S. aureus, they account for 60-80% of cardiovascular implantable electronic device infections 11.

Critical Species-Specific Considerations:

S. lugdunensis requires special attention - despite being coagulase-negative, it should be managed similarly to S. aureus infections due to its aggressive clinical behavior 2, 6. Many laboratories lack the capability to differentiate S. lugdunensis from other CoNS, which can lead to inadequate treatment 1.

Diagnostic Challenges:

The interpretation of CoNS in blood cultures is problematic because these organisms are both the most common contaminants and the most common cause of catheter-related bloodstream infections 6. Multiple positive blood cultures from different sites with the same species and identical antibiotic susceptibility patterns support true infection rather than contamination 11, 6.

Antibiotic Resistance Patterns

Most CoNS are methicillin-resistant, with resistance rates of 70-74% to multiple antibiotics 9, 4, 5. Vancomycin remains 100% effective, though increasing numbers show reduced glycopeptide susceptibility 4, 5. Rifampin plays a special role in prosthetic device infections by helping eradicate bacteria attached to foreign material 9.

References

Research

[Coagulase negative staphylococci isolated on blood cultures].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2001

Research

Coagulase-negative staphylococci.

Clinical microbiology reviews, 2014

Research

Coagulase-Negative Staphylococcus Skin and Soft Tissue Infections.

American journal of clinical dermatology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.